Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | DGKA | P23743 | 1/20 | 0.36 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8946737 | 0.89 | CES2 (0.54) | CES2ALDH1A1TSHRNAAAATM | |
| SCHEMBL28647891 | 0.87 | CES2 (0.42) | CES2ALDH1A1TSHRNAAADGKA | |
| SCHEMBL28356701 | 0.85 | CES2 (0.50) | CES2ALDH1A1TSHRNAAAATM | |
| SCHEMBL15679520 | 0.79 | ALDH1A1 (0.50) | CES2ALDH1A1TSHR | |
| SCHEMBL27639995 | 0.79 | CES2 (0.48) | CES2ALDH1A1TSHRNAAAATM | |
| SCHEMBL1059079 | 0.78 | CES2 (0.52) | CES2ALDH1A1TSHRNAAAATM | |
| SCHEMBL5691833 | 0.78 | TSHR (0.39) | CES2ALDH1A1TSHR | |
| SCHEMBL1055702 | 0.78 | ALDH1A1 (0.54) | CES2ALDH1A1TSHRNAAAATM | |
| SCHEMBL8380874 | 0.78 | — | — | |
| SCHEMBL585566 | 0.78 | ALDH1A1 (0.44) | CES2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112739546-B | Pretreatment liquid, ink set, base material for image recording, process for producing base material for image recording, image recorded matter, and image recording method | 富士胶片株式会社 | 2022-08-19 | — | — | CN | disclosed |
| CN-114845881-A | Image recording method | 富士胶片株式会社 | 2022-08-02 | — | — | CN | disclosed |
| CN-114599747-A | Image recording material and method for producing same | 富士胶片株式会社 | 2022-06-07 | — | — | CN | disclosed |
| CN-112423992-B | Image recording method and image recording system | 富士胶片株式会社 | 2022-03-22 | — | — | CN | disclosed |
| CN-113646176-A | Ink set, image recording method, and image recorded matter | 富士胶片株式会社 | 2021-11-12 | — | — | CN | disclosed |
| CN-113597346-A | Inkjet ink for non-permeable substrate, image recording method, and method for producing laminate | 富士胶片株式会社 | 2021-11-02 | — | — | CN | disclosed |
| CN-112739546-A | Pretreatment liquid, ink set, base material for image recording, method for producing base material for image recording, image recorded matter, and image recording method | 富士胶片株式会社 | 2021-04-30 | — | — | CN | disclosed |
| CN-112423992-A | Image recording method and image recording system | 富士胶片株式会社 | 2021-02-26 | — | — | CN | disclosed |
| CN-111918937-A | Inkjet ink composition, image recording method, and image recorded matter | 富士胶片株式会社 | 2020-11-10 | — | — | CN | disclosed |
| EP-2788336-A1 | BENZOTHIAZOL- 6 -YL ACETIC ACID DERIVATIVES AND THEIR USE FOR TREATING AN HIV INFECTION | Gilead Sciences, Inc. (US) | 2014-10-15 | — | — | EP | disclosed |
| WO-2013159064-A1 | BENZOTHIAZOL- 6 -YL ACETIC ACID DERIVATIVES AND THEIR USE FOR TREATING AN HIV INFECTION | GILEAD SCIENCES, INC. (US) | 2013-10-24 | — | — | WO | disclosed |
| US-5545349-A | Bleaching composition | KAO CORPORATION (JP) | 1996-08-13 | — | — | US | disclosed |
| EP-0447553-B1 | BLEACHING COMPOSITION | KAO CORP (JP) | 1996-06-12 | — | — | EP | disclosed |